NPI: 1952570541 · HESPERIA, CA 92345 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/27/2008
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 02/27/2008 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,384 | $1.63M |
| 2019 | 16,886 | $969K |
| 2020 | 17,794 | $946K |
| 2021 | 19,167 | $779K |
| 2022 | 18,021 | $778K |
| 2023 | 18,388 | $790K |
| 2024 | 13,359 | $1.28M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 41,538 | 3,623 | $7.00M |
| A4657 | Syringe, with or without needle, each | 4,233 | 1,682 | $109K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 29,118 | 2,263 | $27K |
| J1756 | Injection, iron sucrose, 1 mg | 9,407 | 2,298 | $18K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 718 | 378 | $10K |
| 0250 | 7,391 | 390 | $3K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 17,910 | 1,582 | $1K |
| 90661 | 13 | 13 | $339.02 | |
| 90674 | 103 | 100 | $282.76 | |
| 83970 | 1,385 | 1,141 | $69.68 | |
| 85048 | 1,360 | 1,300 | $0.00 | |
| 83540 | 971 | 789 | $0.00 | |
| 85041 | 1,364 | 1,304 | $0.00 | |
| 90662 | 28 | 28 | $0.00 | |
| 82728 | 979 | 801 | $0.00 | |
| 83550 | 865 | 699 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 196 | 183 | $0.00 |
| 82746 | 27 | 27 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 365 | 237 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 28 | 28 | $0.00 |